Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132568) titled 'Clinical Study of CD70-Targeted ImmunoPET/CT Imaging for Primary Tumor Target Volume Delineation in Nasopharyngeal Carcinoma' on Sept. 15.

Study Type: Observational study

Study Design: Cross-sectional

Primary Sponsor: Jiangxi Cancer Hospital?

Condition: nasopharyngeal carcinoma (NPC)

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-10-01

Target Sample Size: Within-subject paired trimodal imaging analysis cohort:61;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=342849

Published by HT Digital Content Services with permis...